Anti-inflammatory effects of metformin in gestational diabetes: Systematic review and meta-analysis of randomized trials and preclinical animal pregnancy models study protocol
Open Access
- 12 November 2026
- journal article
- review article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (11) , e0361047
Abstract
Background: Gestational diabetes mellitus (GDM) is a significant complication that can occur during pregnancy. It is characterized by glucose intolerance that first arises during pregnancy and is associated with insulin resistance, which is linked to elevated inflammatory markers. Metformin has emerged as a promising treatment option for GDM, with growing evidence supporting its anti-inflammatory effects. These effects are thought to be mediated by activation of AMP-activated protein kinase (AMPK) and inhibition of NF-κB signaling. This systematic review aims to assess the anti-inflammatory effects of metformin in GDM, considering both clinical and preclinical studies. Methods: A systematic review of all randomized controlled trials and controlled in vivo experiments for animals published until 2026 will be carried out. A comprehensive search of all published articles indexed in PubMed/MEDLINE, the Cochrane Library, Scopus, CINAHL (EBSCOhost), Embase, and Web of Science will be performed. Studies will be screened for eligibility by title, abstract, and full text in duplicate by two independent reviewers. For data where meta-analysis is not possible, a narrative analysis will be conducted using themes derived from the data. For data that allow meta-analysis, a random-effects meta-analysis will be conducted. This systematic review will be reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA). Discussion: The study will utilize meta-analysis to establish the anti-inflammatory effects of metformin in GDM, potentially influencing clinical practice and guidelines. Additionally, validating metformin’s anti-inflammatory effects has important implications beyond immediate management of GDM, extending to long-term adverse outcomes for both the mother and the offspring. Systematic review registration: PROSPERO CRD420261337881Keywords
This publication has 38 references indexed in Scilit:
- Prevalence and Predictors of Gestational Diabetes Mellitus in Sub‐Saharan Africa: A 10‐Year Systematic ReviewEndocrinology, Diabetes & Metabolism, 2024
- Maternal circulating levels of Adipocytokines and insulin resistance as predictors of gestational diabetes mellitus: preliminary findings of a longitudinal descriptive studyJournal of Diabetes & Metabolic Disorders, 2020
- Gestationsdiabetes (GDM) (Update 2019)Wiener klinische Wochenschrift, 2019
- Metformin Inhibits Chemokine Expression Through the AMPK/NF-κB Signaling PathwayJournal of Interferon & Cytokine Research, 2018
- Pregnancy outcomes in women on metformin for diabetes or other indications among those seeking teratology information servicesBritish Journal of Clinical Pharmacology, 2018
- Metformin Suppresses Lipopolysaccharide (LPS)-induced Inflammatory Response in Murine Macrophages via Activating Transcription Factor-3 (ATF-3) InductionJournal of Biological Chemistry, 2014
- Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: A World Health Organization GuidelineDiabetes Research and Clinical Practice, 2014
- GRADE guidelines: 3. Rating the quality of evidenceJournal of Clinical Epidemiology, 2011
- Epidemiology and causes of preterm birthThe Lancet, 2008
- Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO ConsultationDiabetic Medicine, 1998